Gary Ingenito - Aug 9, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Stock symbol
CPRX
Transactions as of
Aug 9, 2024
Transactions value $
-$1,403,000
Form type
4
Date filed
8/13/2024, 05:01 PM
Previous filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $401K +100K +194.59% $4.01 151K Aug 9, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$1.8M -100K -66.05% $18.04 51.4K Aug 9, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -100K -9.52% $0.00 951K Aug 9, 2024 Common Stock 100K $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $17.58 to $18.25 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.